The current authors done an open up-label pilot study that administered psilocybin to 15 remedy-resistant tobacco/nicotine-dependent people who smoke, in the context of cognitive behavioral therapy for cigarette smoking cessation [fifty eight]. Participants ended up administered ~0.29 mg/kg oral psilocybin over the participant’s concentrate on da